Skip to main content
Equibles
LMAT logo

LMAT · Lemaitre Vascular Inc · Earnings Call Transcripts & Audio

Track LMAT — free

Use LMAT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LMAT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$82.59 -0.30 (-0.36%) At close · Sep 30
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.86B
Shares
22.87M
Volume · Sep 30 207.87K Avg daily vol (3M) 336.01K

Lemaitre Vascular Inc Earnings Call Transcripts

Quarterly earnings calls for Lemaitre Vascular Inc (LMAT), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲1.7% $39.03M $5.46M '22 Q3 22-10-27 ▲3.7% $40.95M $5.63M '22 Q4 23-02-23 ▲19% $47.08M $6.04M '23 Q1 23-05-02 ▲28.4% $50.12M $8.10M '23 Q2 23-08-01 ▲21.5% $47.41M $7.50M '23 Q3 23-11-01 ▲19.4% $48.88M $8.46M '23 Q4 24-02-27 ▲13.6% $53.48M $9.89M '24 Q1 24-05-02 ▲11.4% $55.85M $11.83M '24 Q2 24-08-01 ▲15.6% $54.82M $11.14M '24 Q3 24-10-31 ▲14% $55.72M $11.18M '24 Q4 25-02-27 ▲12% $59.87M $11.01M '25 Q1 25-05-01 ▲15% $64.23M $13.78M '25 Q2 25-08-05 ▲11.4% $61.05M $17.36M '25 Q3 25-11-06 ▲15.7% $64.45M $15.58M '25 Q4 26-02-25 ▲11.2% $66.55M $15.68M '26 Q1 26-05-05 LATEST ▲9.6% $70.38M $17.05M '26 Q2 26-08-04
Conference
Investor event
2026-09-22
Lemaitre Vascular Inc (LMAT) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-11
Lemaitre Vascular Inc (LMAT) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-04
Lemaitre Vascular Inc (LMAT) Q2 2026 Earnings Call Transcript
Positive tone Catheters comparison and recall overhang Sales force and commercial infrastructure buildout Artograph growth and expansion
Revenue
$70.38M
▲ 9.6% YoY
Diluted EPS
$0.74
▲ 23.3% YoY
Gross margin
72.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-05-14
Lemaitre Vascular Inc (LMAT) May 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Lemaitre Vascular Inc (LMAT) Q1 2026 Earnings Call Transcript
Confident tone Geographic expansion and going direct Financial performance and margin expansion Distribution / export business lumpiness
Revenue
$66.55M
▲ 11.2% YoY
Diluted EPS
$0.68
▲ 41.7% YoY
Gross margin
72.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-16
Lemaitre Vascular Inc (LMAT) April 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-11
Lemaitre Vascular Inc (LMAT) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-10
Lemaitre Vascular Inc (LMAT) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-25
Lemaitre Vascular Inc (LMAT) Q4 2025 Earnings Call Transcript
Confident tone Artegraft International Expansion Operating Leverage and Margin Expansion Chicago to Burlington Manufacturing Consolidation
Revenue
$64.45M*
▲ 15.7% YoY
Gross margin
71.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2025-12-04
Lemaitre Vascular Inc (LMAT) December 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2025-11-19
Lemaitre Vascular Inc (LMAT) November 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-06
Lemaitre Vascular Inc (LMAT) Q3 2025 Earnings Call Transcript
Confident tone Gross margin and operating leverage Artegraft and RestoreFlow international expansion Organic sales growth and product performance
Revenue
$61.05M
▲ 11.4% YoY
Diluted EPS
$0.75
▲ 53.1% YoY
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Lemaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Transcript
Confident tone Artegraft international launch RestoreFlow allograft expansion Guidance raise and financial performance
Revenue
$64.23M
▲ 15% YoY
Diluted EPS
$0.60
▲ 15.4% YoY
Gross margin
70.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Lemaitre Vascular Inc (LMAT) Q1 2025 Earnings Call Transcript
Revenue
$59.87M
▲ 12% YoY
Diluted EPS
$0.48
▲ 9.1% YoY
Gross margin
69.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Lemaitre Vascular Inc (LMAT) Q4 2024 Earnings Call Transcript
Confident tone Product portfolio performance Regulatory / MDR CE Mark progress Sales force expansion
Revenue
$55.72M*
▲ 14% YoY
Gross margin
69.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Lemaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Transcript
Confident tone Margin and profitability Top-line growth and pricing Allograft international expansion
Revenue
$54.82M
▲ 15.6% YoY
Diluted EPS
$0.49
▲ 48.5% YoY
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Lemaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Transcript
Confident tone MDR CE Mark Regulatory Progress ERP Implementation Gross Margin Expansion
Revenue
$55.85M
▲ 11.4% YoY
Diluted EPS
$0.52
▲ 44.4% YoY
Gross margin
68.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Lemaitre Vascular Inc (LMAT) Q1 2024 Earnings Call Transcript
Confident tone ODR mix shift strategy Strategic acquisitions / M&A pipeline Vertical market demand
Revenue
$53.48M
▲ 13.6% YoY
Diluted EPS
$0.44
▲ 63% YoY
Gross margin
68.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Lemaitre Vascular Inc (LMAT) Q4 2023 Earnings Call Transcript
Confident tone Gross Margin Expansion and Manufacturing Artegraft Acquisition Integration and International Filings Sales Force Expansion and Territory Reorganization
Revenue
$48.88M
▲ 19.4% YoY
Diluted EPS
$0.38
▲ 52% YoY
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Lemaitre Vascular Inc (LMAT) Q3 2023 Earnings Call Transcript
Revenue
$47.41M
▲ 21.5% YoY
Diluted EPS
$0.33
▲ 32% YoY
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Lemaitre Vascular Inc (LMAT) Q2 2023 Earnings Call Transcript
Revenue
$50.12M
▲ 28.4% YoY
Diluted EPS
$0.36
▲ 125% YoY
Gross margin
64.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Lemaitre Vascular Inc (LMAT) Q1 2023 Earnings Call Transcript
Revenue
$47.08M
▲ 19% YoY
Diluted EPS
$0.27
▲ 0% YoY
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Lemaitre Vascular Inc (LMAT) Q4 2022 Earnings Call Transcript
Revenue
$40.95M
▲ 3.7% YoY
Diluted EPS
$0.25
▼ 10.7% YoY
Gross margin
63.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Lemaitre Vascular Inc (LMAT) Q3 2022 Earnings Call Transcript
Revenue
$39.03M
▲ 1.7% YoY
Diluted EPS
$0.25
▼ 16.7% YoY
Gross margin
64.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Lemaitre Vascular Inc (LMAT) Q2 2022 Earnings Call Transcript
Revenue
$39.03M
▼ 4% YoY
Diluted EPS
$0.16
▼ 60% YoY
Gross margin
71.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Lemaitre Vascular Inc (LMAT) Q1 2022 Earnings Call Transcript
Revenue
$39.56M
▲ 10.2% YoY
Diluted EPS
$0.27
▼ 3.6% YoY
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Lemaitre Vascular Inc (LMAT) Q4 2021 Earnings Call Transcript
Revenue
$39.50M
▲ 5.2% YoY
Diluted EPS
$0.28
▼ 17.6% YoY
Gross margin
65.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Lemaitre Vascular Inc (LMAT) Q3 2021 Earnings Call Transcript
Revenue
$38.37M
▲ 5.4% YoY
Diluted EPS
$0.30
▼ 18.9% YoY
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-13
Lemaitre Vascular Inc (LMAT) Q2 2021 Earnings Call Transcript
Revenue
$40.67M
▲ 63.7% YoY
Diluted EPS
$0.40
▲ 135.3% YoY
Gross margin
65.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Lemaitre Vascular Inc (LMAT) Q1 2021 Earnings Call Transcript
Revenue
$35.88M
▲ 17.5% YoY
Diluted EPS
$0.28
▲ 75% YoY
Gross margin
66.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Lemaitre Vascular Inc (LMAT) Q4 2020 Earnings Call Transcript
Revenue
$37.55M
▲ 24.5% YoY
Diluted EPS
$0.34
▲ 47.8% YoY
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Lemaitre Vascular Inc (LMAT) Q3 2020 Earnings Call Transcript
Revenue
$36.42M
▲ 25.1% YoY
Diluted EPS
$0.37
▲ 48% YoY
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Lemaitre Vascular Inc (LMAT) Q2 2020 Earnings Call Transcript
Revenue
$24.85M
▼ 15.7% YoY
Diluted EPS
$0.17
▼ 26.1% YoY
Gross margin
68.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Lemaitre Vascular Inc (LMAT) Q1 2020 Earnings Call Transcript
Revenue
$30.55M
▲ 7.3% YoY
Diluted EPS
$0.16
▼ 5.9% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-06
Lemaitre Vascular Inc (LMAT) Q4 2019 Earnings Call
Revenue
$30.17M
▲ 6.3% YoY
Diluted EPS
$0.23
▼ 23.3% YoY
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–35 of 35 earnings calls
Key facts CIK 1158895 CUSIP 525558201 13F (30d) 7 filings 7 filers Visit website Investor relations